Northern Right Capital Management’s Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares FLAC Stock Holding History

Northern Right Capital Management’s Portfolio FLAC Stock Details FLAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-29,214	Closed	-$291K	–	108
2021 Q1	$291K	Buy	+29,214	New	+$298K	0.08%	73

Other funds holding FLAC

Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

DCM

DG Capital Management New York $475M AUM 36.12% 1-Year Est. Return

MYDA Advisors Woodmere, New York $672M AUM 71.14% 1-Year Est. Return

Governors Lane New York $1.2B AUM 26.21% 1-Year Est. Return

GCM

Ghisallo Capital Management Boston, Massachusetts $5.1B AUM 39.13% 1-Year Est. Return

ESCM

Echo Street Capital Management New York $747M AUM 24.25% 1-Year Est. Return

RCM

Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.32B AUM 1.82% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Athanor Capital New York $24.6M AUM 2.49% 1-Year Est. Return

Northern Right Capital Management's FLAC Position: Q2 2021 in Review

Northern Right Capital Management sold out of Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares (FLAC) in Q2 2021, closing a stake of 29,214 shares — an estimated $291K sold.

Northern Right Capital Management first reported a position in FLAC in Q1 2021 and held it in 1 quarter. The position peaked at $291K in Q1 2021. 41 funds tracked by Wall St. Rank hold FLAC as of Q2 2021.

Northern Right Capital Management reported no remaining Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares position as of Q2 2021 after selling out during the quarter.
Northern Right Capital Management sold 29,214 Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares shares in Q2 2021, an estimated $291K.
Northern Right Capital Management first reported a position in Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares in Q1 2021 and held it in 1 quarter.
Northern Right Capital Management's Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares position peaked at $291K in Q1 2021.
41 funds tracked by Wall St. Rank held Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares as of Q2 2021.

Based on Northern Right Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.